Epstein-Barr virus in Hodgkin's disease and site of origin of tumour

Lancet. 1994 Jan 29;343(8892):265-6. doi: 10.1016/s0140-6736(94)91114-2.

Abstract

Epstein-Barr virus (EBV) may be involved in the pathogenesis of Hodgkin's disease. We investigated whether EBV in Hodgkin's disease is related to the site of origin of the tumour. In 40 patients with stage I disease, there was a significant association between EBV latent membrane protein (LMP-1) expression and presentation in neck lymph nodes. There was no association in stage II-IV disease (57 cases). Nodular sclerosing subtype was rarely associated with LMP-1 expression. In some cases of Hodgkin's disease of mixed cellularity or lymphocyte predominant subtype originating in the neck, EBV may be an important aetiological co-factor.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antigens, Viral* / genetics
  • Axilla*
  • Biopsy
  • Capsid* / genetics
  • Capsid* / immunology
  • Female
  • Gene Expression*
  • Groin*
  • Head and Neck Neoplasms / classification
  • Head and Neck Neoplasms / epidemiology
  • Head and Neck Neoplasms / microbiology*
  • Head and Neck Neoplasms / pathology
  • Herpesvirus 4, Human* / genetics
  • Herpesvirus 4, Human* / immunology
  • Hodgkin Disease / classification
  • Hodgkin Disease / epidemiology
  • Hodgkin Disease / microbiology*
  • Hodgkin Disease / pathology
  • Humans
  • Immunohistochemistry
  • Logistic Models
  • Lymphatic Metastasis
  • Male
  • Mediastinal Neoplasms / classification
  • Mediastinal Neoplasms / epidemiology
  • Mediastinal Neoplasms / microbiology*
  • Mediastinal Neoplasms / pathology
  • Neoplasm Staging
  • Viral Matrix Proteins* / genetics

Substances

  • Antigens, Viral
  • EBV-associated membrane antigen, Epstein-Barr virus
  • Viral Matrix Proteins